Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-04-23

FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for allopurinol submitted by Zydus Lifesciences Limited, indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)